In the second and final day of the…
In the second and final day of the CDC’s Advisory [...]
In the second and final day of the CDC’s Advisory [...]
The FDA has approved Merck & Co.’s under-the-skin version of [...]
Takeda employees from around the world climbed Mount Fuji, a [...]
The CDC’s recommendation for Gilead’s twice-yearly Yeztugo as an HIV [...]
Europe’s Committee for Medicinal Products for Human Use (CHMP) has [...]
It’s been less than two years since Roche dove into [...]
In a perplexing conclusion to an oftentimes tense meeting of [...]
The German drug developer has tapped four industry leaders to [...]
Renowned biotech veteran Robert Langer is the executive chair of [...]
In addition to manufacturing drug substance for argenx’s autoimmune blockbuster [...]